$OGEN
ORAGENICS INC

2012 Q2 Form 10-Q Financial Statement

#000119312512233087 Filed on May 15, 2012

View on sec.gov

Income Statement

Concept 2012 Q2 2012 Q1 2011 Q4
Revenue $256.4K $380.5K $400.0K
YoY Change -26.74% 8.74% 33.33%
Cost Of Revenue $112.3K $198.2K $160.0K
YoY Change -65.98% 108.69% -63.64%
Gross Profit $144.1K $182.3K $240.0K
YoY Change 620.75% -28.49% -271.43%
Gross Profit Margin 56.22% 47.91% 60.0%
Selling, General & Admin $835.5K $1.308M $1.210M
YoY Change -50.56% -3.64% -18.79%
% of Gross Profit 579.59% 717.42% 504.17%
Research & Development $6.177M $353.2K $840.0K
YoY Change 880.54% -14.46% 31.25%
% of Gross Profit 4285.41% 193.73% 350.0%
Depreciation & Amortization $20.00K $19.57K $20.00K
YoY Change 0.0% -2.61% 100.0%
% of Gross Profit 13.87% 10.73% 8.33%
Operating Expenses $7.013M $1.661M $2.050M
YoY Change 202.28% -6.17% -3.76%
Operating Profit -$6.869M -$1.479M -$1.810M
YoY Change 198.64% -2.41% -20.26%
Interest Expense $60.11K $138.3K -$120.0K
YoY Change -185.87% 215.81% 300.0%
% of Operating Profit
Other Income/Expense, Net -$60.07K -$138.0K $0.00
YoY Change 216.4% -100.0%
Pretax Income -$6.929M -$1.617M -$1.940M
YoY Change 192.35% 3.71% -33.33%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$6.929M $1.617M -$1.940M
YoY Change 192.35% -203.71% -10.6%
Net Earnings / Revenue -2702.26% 424.91% -485.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$5.172M -$2.531M -$3.345M
COMMON SHARES
Basic Shares Outstanding 12.17M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2012 Q2 2012 Q1 2011 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.130M $970.0K $170.0K
YoY Change 1516.67% 30.77%
Cash & Equivalents $1.130M $967.9K $171.7K
Short-Term Investments
Other Short-Term Assets $350.0K $410.0K $370.0K
YoY Change -37.5% -24.07% -40.32%
Inventory $350.0K $363.0K $475.6K
Prepaid Expenses
Receivables $40.00K $63.31K $92.64K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.870M $1.812M $1.118M
YoY Change 66.96% 86.82% -25.45%
LONG-TERM ASSETS
Property, Plant & Equipment $110.0K $129.1K $148.7K
YoY Change -42.11% -38.51% -35.35%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $110.0K $129.1K $148.7K
YoY Change -42.11% -38.51% -35.35%
TOTAL ASSETS
Total Short-Term Assets $1.870M $1.812M $1.118M
Total Long-Term Assets $110.0K $129.1K $148.7K
Total Assets $1.980M $1.941M $1.267M
YoY Change 51.15% 64.52% -26.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.250M $1.260M $1.740M
YoY Change -22.36% -3.82% 15.23%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $40.00K $70.00K $50.00K
YoY Change -42.86% -36.36% -50.0%
Long-Term Debt Due $0.00 $0.00 $7.500M
YoY Change
Total Short-Term Liabilities $1.380M $1.482M $9.446M
YoY Change -22.91% -2.52% 479.53%
LONG-TERM LIABILITIES
Long-Term Debt $2.060M $770.0K $0.00
YoY Change -54.22% -74.33% -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $2.060M $770.0K $0.00
YoY Change -54.22% -74.33% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.380M $1.482M $9.446M
Total Long-Term Liabilities $2.060M $770.0K $0.00
Total Liabilities $3.430M $2.260M $9.450M
YoY Change -45.47% -50.0% 160.33%
SHAREHOLDERS EQUITY
Retained Earnings -$42.61M -$41.00M
YoY Change
Common Stock $12.18K $5.894K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.450M -$314.3K -$8.179M
YoY Change
Total Liabilities & Shareholders Equity $1.980M $1.941M $1.267M
YoY Change 51.15% 64.52% -26.77%

Cashflow Statement

Concept 2012 Q2 2012 Q1 2011 Q4
OPERATING ACTIVITIES
Net Income -$6.929M $1.617M -$1.940M
YoY Change 192.35% -203.71% -10.6%
Depreciation, Depletion And Amortization $20.00K $19.57K $20.00K
YoY Change 0.0% -2.61% 100.0%
Cash From Operating Activities -$1.150M -$1.143M -$1.390M
YoY Change -21.23% 1.73% -21.47%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.310M 1.939M 1.560M
YoY Change -6.43% 85.06% 19.08%
NET CHANGE
Cash From Operating Activities -1.150M -1.143M -1.390M
Cash From Investing Activities 0.000
Cash From Financing Activities 1.310M 1.939M 1.560M
Net Change In Cash 160.0K 796.2K 170.0K
YoY Change -366.67% -1152.21% -145.95%
FREE CASH FLOW
Cash From Operating Activities -$1.150M -$1.143M -$1.390M
Capital Expenditures $0.00
Free Cash Flow -$1.390M
YoY Change -25.27%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12174795 shares
CY2011Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56433
CY2012Q1 us-gaap Short Term Non Bank Loans And Notes Payable
ShortTermNonBankLoansAndNotesPayable
71578
CY2012Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1481669
CY2012Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
773904
CY2012Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
145196
CY2012Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-42612824
CY2012Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
123852
CY2012Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
294104
CY2012Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
63314
CY2012Q1 us-gaap Assets
Assets
1941320
CY2012Q1 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2012Q1 us-gaap Common Stock Value
CommonStockValue
12175
CY2012Q1 us-gaap Inventory Net
InventoryNet
362985
CY2012Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12174795 shares
CY2012Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2012Q1 us-gaap Assets Current
AssetsCurrent
1812199
CY2012Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
967944
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
42286396
CY2012Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1264895
CY2012Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1941320
CY2012Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q1 us-gaap Stockholders Equity
StockholdersEquity
-314253
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12174795 shares
CY2012Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
129121
CY2012Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000 shares
CY2012Q1 orni Restricted Common Stock Par Or Stated Value Per Share
RestrictedCommonStockParOrStatedValuePerShare
5
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
132103
CY2011Q4 us-gaap Short Term Non Bank Loans And Notes Payable
ShortTermNonBankLoansAndNotesPayable
53092
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9446270
CY2011Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
152962
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-40995916
CY2011Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
113331
CY2011Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
264960
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
92644
CY2011Q4 us-gaap Assets
Assets
1266952
CY2011Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
5894
CY2011Q4 us-gaap Inventory Net
InventoryNet
475592
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5894176 shares
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2011Q4 us-gaap Assets Current
AssetsCurrent
1118266
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
171739
CY2011Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
7500000
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2011Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
32810704
CY2011Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1740216
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1266952
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
-8179318
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5894176 shares
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
148686
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000 shares
CY2011Q1 us-gaap Gross Profit
GrossProfit
254960
CY2011Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-362218
CY2011Q1 us-gaap Stock Issued1
StockIssued1
20
CY2011Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
177
CY2011Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-27124
CY2011Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
94977
CY2011Q1 us-gaap Revenues
Revenues
349937
CY2011Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1123621
CY2011Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1559013
CY2011Q1 us-gaap Share Based Compensation
ShareBasedCompensation
118929
CY2011Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-203205
CY2011Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
22
CY2011Q1 us-gaap Interest Expense
InterestExpense
43781
CY2011Q1 us-gaap Net Income Loss
NetIncomeLoss
-1559013
CY2011Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1000000
CY2011Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-43626
CY2011Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
412901
CY2011Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20090
CY2011Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1515387
CY2011Q1 us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
86876
CY2011Q1 us-gaap Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
38925
CY2011Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1357446
CY2011Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-75670
CY2011Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-34945
CY2011Q1 us-gaap Interest Paid
InterestPaid
1702
CY2011Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8389
CY2011Q1 us-gaap Operating Expenses
OperatingExpenses
1770347
CY2011Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
83680
CY2011Q1 us-gaap Notes Issued1
NotesIssued1
48988
CY2011Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1047951
CY2011Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.275
CY2011Q1 orni Weighted Average Number Basic Diluted Shares Outstanding
WeightedAverageNumberBasicDilutedSharesOutstanding
5667521 shares
CY2012Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2012Q1 dei Trading Symbol
TradingSymbol
ORNI
CY2012Q1 dei Entity Registrant Name
EntityRegistrantName
ORAGENICS INC
CY2012Q1 dei Amendment Flag
AmendmentFlag
false
CY2012Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2012Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
CY2012Q1 dei Document Type
DocumentType
10-Q
CY2012Q1 dei Document Period End Date
DocumentPeriodEndDate
2012-03-31
CY2012Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001174940
CY2012Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2012Q1 us-gaap Gross Profit
GrossProfit
182318
CY2012Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
383
CY2012Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-29330
CY2012Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
198209
CY2012Q1 us-gaap Revenues
Revenues
380527
CY2012Q1 orni Weighted Average Number Basic Diluted Shares Outstanding
WeightedAverageNumberBasicDilutedSharesOutstanding
6449342 shares
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1143100
CY2012Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1616908
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
261403
CY2012Q1 us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
1250000
CY2012Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
11690
CY2012Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
152
CY2012Q1 us-gaap Interest Expense
InterestExpense
138265
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-1616908
CY2012Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
750000
CY2012Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-138034
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
353198
CY2012Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19565
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1478874
CY2012Q1 us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
-29144
CY2012Q1 us-gaap Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
31551
CY2012Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1307994
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
796205
CY2012Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-39516
CY2012Q1 us-gaap Interest Paid
InterestPaid
447
CY2012Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-112607
CY2012Q1 us-gaap Operating Expenses
OperatingExpenses
1661192
CY2012Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-7766
CY2012Q1 us-gaap Notes Issued1
NotesIssued1
50037
CY2012Q1 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
8737011
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1939305
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.250
CY2012Q1 orni Discount On Convertible Notes Related To Warrants
DiscountOnConvertibleNotesRelatedToWarrants
483559
CY2012Q1 orni Accretion Of Discount On Note Payable To Related Party
AccretionOfDiscountOnNotePayableToRelatedParty
7463

Files In Submission

Name View Source Status
0001193125-12-233087-index-headers.html Edgar Link pending
0001193125-12-233087-index.html Edgar Link pending
0001193125-12-233087.txt Edgar Link pending
0001193125-12-233087-xbrl.zip Edgar Link pending
d333982d10q.htm Edgar Link pending
d333982dex105.htm Edgar Link pending
d333982dex106.htm Edgar Link pending
d333982dex107.htm Edgar Link pending
d333982dex311.htm Edgar Link pending
d333982dex312.htm Edgar Link pending
d333982dex321.htm Edgar Link pending
d333982dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
orni-20120331.xml Edgar Link completed
orni-20120331.xsd Edgar Link pending
orni-20120331_cal.xml Edgar Link unprocessable
orni-20120331_def.xml Edgar Link unprocessable
orni-20120331_lab.xml Edgar Link unprocessable
orni-20120331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending